経腸栄養製剤市場-世界の産業規模、シェア、動向、機会、予測、製品タイプ別、フロータイプ別、ステージ別、適応症別、エンドユース別、地域別、競合別、2020-2030F

経腸栄養製剤の世界市場規模は2024年に67億5,000万米ドルに達し、2030年までのCAGRは6.75%で、予測期間中に着実な成長が予測されています。

世界のヘルスケア産業はパラダイムシフトを迎えており、全人的な患者ケアへの注目が高まっています。患者の幸福に不可欠な側面の1つは栄養であり、病状により経口摂取ができない個人にとって、経腸栄養製剤は極めて重要なソリューションとして浮上しています。

経腸栄養製剤の世界市場は、未熟児から高齢者まで、回復と全身の健康のために必要な栄養素を確実に摂取できるようにする上で極めて重要な役割を果たしています。経腸栄養は、チューブを介して消化管に直接栄養を供給します。この方法は、嚥下障害、消化器系の問題、重篤な疾患などのために、経口的に食物を摂取できない場合に採用されます。経腸栄養製剤は、経腸栄養剤または経管栄養剤としても知られ、多量栄養素、ビタミン、ミネラルをバランスよく配合した特殊な液体溶液です。乳児用調製粉乳は、乳児から成人までのさまざまな患者グループの特定の栄養ニーズに適合するように設計されています。標準製剤、疾患特異的製剤、糖尿病や腎不全のような特定の病状に特化した製剤など、さまざまなタイプに分類することができます。世界の高齢化社会では、さまざまな健康状態に陥りやすく、それが正常な食事能力に影響を及ぼす可能性があります。このため、高齢者の栄養ニーズに合わせた経腸栄養製剤の需要が増加しています。

主な市場促進要因

慢性疾患の有病率の上昇

主な市場課題

規制上のハードル

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 経腸栄養製剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（標準処方、疾患別処方）
  • フロータイプ別（間欠供給フロー、連続供給フロー）
  • ステージ別（成人、小児）
  • 適応症別（アルツハイマー病、栄養失調、がん治療、糖尿病、慢性腎臓病、希少疾患、嚥下障害、疼痛管理、吸収不良/消化管障害/下痢、その他）
  • 用途別（病院、在宅ケア）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の経腸栄養製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の経腸栄養製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の経腸栄養製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の経腸栄養製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの経腸栄養製剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の経腸栄養製剤市場：SWOT分析

第14章 競合情勢

• Abbott Laboratories Inc
• Danone S.A
• Fresenius Kabi AG
• Nestle S.A.
• VICTUS Inc.
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co Ltd.
• Mead Johnson & Company, LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Enteral Feeding Formulas Market was valued at USD 6.75 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 6.75% through 2030. The global healthcare industry is undergoing a paradigm shift, with a growing focus on holistic patient care. One essential aspect of patient well-being is nutrition, and for individuals who cannot consume food orally due to medical conditions, enteral feeding formulas have emerged as a crucial solution.

The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the essential nutrients they need for recovery and overall health. Enteral feeding involves providing nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals are unable to consume food orally due to conditions such as swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, ranging from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations for specific medical conditions like diabetes or renal failure. The world's aging population is prone to a range of health conditions that can affect their ability to eat normally. This has led to an increased demand for enteral feeding formulas tailored to the nutritional needs of the elderly.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global enteral feeding formulas market is witnessing substantial growth, primarily driven by the increasing prevalence of chronic diseases. In 2021, cardiovascular diseases remained the leading cause of mortality among non-communicable diseases (NCDs), accounting for at least 19 million deaths. Cancer followed closely, responsible for 10 million fatalities, while chronic respiratory diseases and diabetes contributed to 4 million and over 2 million deaths, respectively including kidney disease deaths linked to diabetes. Collectively, these four disease categories were responsible for 80% of all premature NCD-related deaths, underscoring their significant impact on global healthcare systems and the urgent need for targeted medical and nutritional interventions. As the global burden of conditions such as cancer, neurological disorders, diabetes, and gastrointestinal diseases continues to rise, the demand for enteral nutrition as a critical component of patient care is expanding. In 2020, cancer was a major global health burden, causing nearly 10 million deaths-equivalent to approximately one in every six fatalities worldwide. Chronic diseases often lead to conditions that impair normal eating and digestion, necessitating the use of enteral feeding formulas to ensure proper nutrient intake. For instance, cancer patients undergoing chemotherapy frequently experience severe appetite loss and gastrointestinal complications, making enteral nutrition essential for maintaining strength and immune function. Similarly, neurological disorders such as Parkinson's disease, multiple sclerosis, and stroke often cause dysphagia (difficulty swallowing), further driving demand for liquid-based nutritional support.

Key Market Challenges

Regulatory Hurdles and

One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.

Key Market Trends

Technological Advancements

Technological advancements in the field of enteral feeding formulas have touched various aspects of the market, revolutionizing both product development and administration methods. Technological innovations have enabled the development of highly specialized and nutritionally advanced enteral feeding formulas. These formulas are designed to cater to the specific nutritional requirements of patients with varying medical conditions, such as diabetes, renal failure, and gastrointestinal disorders. Through precise formulation and the inclusion of bioactive ingredients, these advanced formulas contribute to better patient recovery and improved overall health. Incorporation of cutting-edge delivery systems has revolutionized how enteral nutrition is administered. The development of pumps with programmable features has allowed for the precise delivery of enteral feeding formulas, ensuring that patients receive the required nutrients at the right rate and consistency. Such devices also minimize the risk of overfeeding or underfeeding, reducing potential complications. The integration of Internet of Things (IoT) technology has led to the creation of smart feeding pumps and monitoring devices. These devices can transmit real-time data about patients' nutritional intake, tube placement, and feeding progress to healthcare professionals.

Key Market Players

• Abbott Laboratories Inc
• Danone S.A
• Fresenius Kabi AG
• Nestle S.A.
• VICTUS Inc.
  • Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co Ltd.
• Mead Johnson & Company, LLC

Report Scope:

In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteral Feeding Formulas Market, By Product:

• Standard Formula
• Disease-specific Formulas

Enteral Feeding Formulas Market, By Flow Type:

• Intermittent Feeding Flow
• Continuous Feeding Flow

Enteral Feeding Formulas Market, By Stage:

• Adults
• Pediatrics

Enteral Feeding Formulas Market, By Indication:

• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Enteral Feeding Formulas Market, By End User:

• Hospitals
• Homecare

Enteral Feeding Formulas Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.

Available Customizations:

Global Enteral Feeding Formulas Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Enteral Feeding Formulas Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Standard Formula, Disease-specific Formulas)
  • 5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
  • 5.2.3. By Stage (Adults, Pediatrics)
  • 5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
  • 5.2.5. By End-Use (Hospitals, Homecare)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Enteral Feeding Formulas Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Flow Type
  • 6.2.3. By Stage
  • 6.2.4. By Indication
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Enteral Feeding Formulas Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Flow Type
      • 6.3.1.2.3. By Stage
      • 6.3.1.2.4. By Indication
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Enteral Feeding Formulas Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Flow Type
      • 6.3.2.2.3. By Stage
      • 6.3.2.2.4. By Indication
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Enteral Feeding Formulas Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Flow Type
      • 6.3.3.2.3. By Stage
      • 6.3.3.2.4. By Indication
      • 6.3.3.2.5. By End User

7. Europe Enteral Feeding Formulas Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Flow Type
  • 7.2.3. By Stage
  • 7.2.4. By Indication
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Enteral Feeding Formulas Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Flow Type
      • 7.3.1.2.3. By Stage
      • 7.3.1.2.4. By Indication
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Enteral Feeding Formulas Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Flow Type
      • 7.3.2.2.3. By Stage
      • 7.3.2.2.4. By Indication
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Enteral Feeding Formulas Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Flow Type
      • 7.3.3.2.3. By Stage
      • 7.3.3.2.4. By Indication
      • 7.3.3.2.5. By End User
  • 7.3.4. France Enteral Feeding Formulas Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Flow Type
      • 7.3.4.2.3. By Stage
      • 7.3.4.2.4. By Indication
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Enteral Feeding Formulas Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Flow Type
      • 7.3.5.2.3. By Stage
      • 7.3.5.2.4. By Indication
      • 7.3.5.2.5. By End User

8. Asia-Pacific Enteral Feeding Formulas Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Flow Type
  • 8.2.3. By Stage
  • 8.2.4. By Indication
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Enteral Feeding Formulas Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Flow Type
      • 8.3.1.2.3. By Stage
      • 8.3.1.2.4. By Indication
      • 8.3.1.2.5. By End User
  • 8.3.2. India Enteral Feeding Formulas Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Flow Type
      • 8.3.2.2.3. By Stage
      • 8.3.2.2.4. By Indication
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Enteral Feeding Formulas Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Flow Type
      • 8.3.3.2.3. By Stage
      • 8.3.3.2.4. By Indication
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Enteral Feeding Formulas Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Flow Type
      • 8.3.4.2.3. By Stage
      • 8.3.4.2.4. By Indication
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Enteral Feeding Formulas Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Flow Type
      • 8.3.5.2.3. By Stage
      • 8.3.5.2.4. By Indication
      • 8.3.5.2.5. By End User

9. South America Enteral Feeding Formulas Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Flow Type
  • 9.2.3. By Stage
  • 9.2.4. By Indication
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Enteral Feeding Formulas Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Flow Type
      • 9.3.1.2.3. By Stage
      • 9.3.1.2.4. By Indication
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Enteral Feeding Formulas Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Flow Type
      • 9.3.2.2.3. By Stage
      • 9.3.2.2.4. By Indication
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Enteral Feeding Formulas Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Flow Type
      • 9.3.3.2.3. By Stage
      • 9.3.3.2.4. By Indication
      • 9.3.3.2.5. By End User

10. Middle East and Africa Enteral Feeding Formulas Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Flow Type
  • 10.2.3. By Stage
  • 10.2.4. By Indication
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Enteral Feeding Formulas Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Flow Type
      • 10.3.1.2.3. By Stage
      • 10.3.1.2.4. By Indication
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Flow Type
      • 10.3.2.2.3. By Stage
      • 10.3.2.2.4. By Indication
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Enteral Feeding Formulas Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Flow Type
      • 10.3.3.2.3. By Stage
      • 10.3.3.2.4. By Indication
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Enteral Feeding Formulas Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Danone S.A
• 14.3. Fresenius Kabi AG
• 14.4. Nestle S.A.
• 14.5. VICTUS Inc.
• 14.6. Primus Pharmaceuticals, Inc.
• 14.7. Meiji Holdings. Co Ltd.
• 14.8. Mead Johnson & Company, LLC

15. Strategic Recommendations

16. About Us & Disclaimer